247 related articles for article (PubMed ID: 8667206)
1. NG-nitro-L-arginine methyl ester attenuates the maintenance and expression of methamphetamine-induced behavioral sensitization and enhancement of striatal dopamine release.
Inoue H; Arai I; Shibata S; Watanabe S
J Pharmacol Exp Ther; 1996 Jun; 277(3):1424-30. PubMed ID: 8667206
[TBL] [Abstract][Full Text] [Related]
2. Lack of effect of Nomega-nitro-L-arginine methyl ester on bromocriptine-induced locomotor sensitization in mice.
Kayir H; Ceyhan M; Yavuz O; Uzbay IT
Synapse; 2007 Oct; 61(10):869-74. PubMed ID: 17623833
[TBL] [Abstract][Full Text] [Related]
3. Reversal of methamphetamine-induced behavioral sensitization by repeated administration of a dopamine D1 receptor agonist.
Shuto T; Kuroiwa M; Hamamura M; Yabuuchi K; Shimazoe T; Watanabe S; Nishi A; Yamamoto T
Neuropharmacology; 2006 Jun; 50(8):991-7. PubMed ID: 16563442
[TBL] [Abstract][Full Text] [Related]
4. Effect of nitric oxide synthase inhibitor and NMDA receptor antagonist on the development of nicotine sensitization of nucleus accumbens dopamine release: an in vivo microdialysis study.
Hong SK; Jung IS; Bang SA; Kim SE
Neurosci Lett; 2006 Dec; 409(3):220-3. PubMed ID: 17046158
[TBL] [Abstract][Full Text] [Related]
5. Striatal acetylcholine release correlates with behavioral sensitization in rats withdrawn from chronic amphetamine.
Bickerdike MJ; Abercrombie ED
J Pharmacol Exp Ther; 1997 Aug; 282(2):818-26. PubMed ID: 9262346
[TBL] [Abstract][Full Text] [Related]
6. [Experimental study of methamphetamine psychosis--role of glutamate and nitric oxide in methamphetamine-induced dopaminergic and serotonergic neurotoxicity in the rat brain].
Abekawa T
Hokkaido Igaku Zasshi; 1997 Jan; 72(1):113-26. PubMed ID: 9086367
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of dopamine release from the striatum through metabotropic glutamate receptor activation in methamphetamine sensitized rats.
Arai I; Shimazoe T; Shibata S; Inoue H; Yoshimatsu A; Watanabe S
Brain Res; 1996 Aug; 729(2):277-80. PubMed ID: 8877000
[TBL] [Abstract][Full Text] [Related]
8. Agmatine inhibits morphine-induced locomotion sensitization and morphine-induced changes in striatal dopamine and metabolites in rats.
Wei XL; Su RB; Wu N; Lu XQ; Zheng JQ; Li J
Eur Neuropsychopharmacol; 2007 Dec; 17(12):790-9. PubMed ID: 17604969
[TBL] [Abstract][Full Text] [Related]
9. [Changes in behavior and central monoaminergic systems in the rat after repeated methamphetamine pretreatment: presynaptic regulatory mechanism].
Ichikawa J
Yakubutsu Seishin Kodo; 1988 Sep; 8(3):389-403. PubMed ID: 3250152
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide mediates glutamate-evoked dopamine release in the medial preoptic area.
Dominguez JM; Muschamp JW; Schmich JM; Hull EM
Neuroscience; 2004; 125(1):203-10. PubMed ID: 15051159
[TBL] [Abstract][Full Text] [Related]
11. Effect of antioxidant N-acetyl-L-cysteine on behavioral changes and neurotoxicity in rats after administration of methamphetamine.
Fukami G; Hashimoto K; Koike K; Okamura N; Shimizu E; Iyo M
Brain Res; 2004 Jul; 1016(1):90-5. PubMed ID: 15234256
[TBL] [Abstract][Full Text] [Related]
12. The effects of FK506, a specific calcineurin inhibitor, on methamphetamine-induced behavioral change and its sensitization in rats.
Tsukamoto T; Iyo M; Tani K; Sekine Y; Hashimoto K; Ohashi Y; Suzuki K; Iwata Y; Mori N
Psychopharmacology (Berl); 2001 Nov; 158(2):107-13. PubMed ID: 11702083
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of nitric oxide synthase attenuates osmotic thirst in the rat.
Kannan H; Iki K; Kunitake T; Shimokawa A; Saita M; Ishizuka Y; Hanamori T
Neurobiology (Bp); 1995; 3(3-4):363-70. PubMed ID: 8696304
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide and the neurotoxic effects of methamphetamine and 3,4-methylenedioxymethamphetamine.
Taraska T; Finnegan KT
J Pharmacol Exp Ther; 1997 Feb; 280(2):941-7. PubMed ID: 9023310
[TBL] [Abstract][Full Text] [Related]
15. Influence of nitric oxide synthase inhibitors on the ACTH and cytokine responses to peripheral immune signals.
Kim CK; Rivier C
J Neuroendocrinol; 1998 May; 10(5):353-62. PubMed ID: 9663649
[TBL] [Abstract][Full Text] [Related]
16. Behavioral, neuroendocrine and thermoregulatory actions of apelin-13.
Jászberényi M; Bujdosó E; Telegdy G
Neuroscience; 2004; 129(3):811-6. PubMed ID: 15541902
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide synthase inhibitors block behavioral sensitization to methamphetamine in mice.
Ohno M; Watanabe S
Eur J Pharmacol; 1995 Feb; 275(1):39-44. PubMed ID: 7539765
[TBL] [Abstract][Full Text] [Related]
18. Attenuation by the 5-HT1A receptor agonist osemozotan of the behavioral effects of single and repeated methamphetamine in mice.
Ago Y; Nakamura S; Uda M; Kajii Y; Abe M; Baba A; Matsuda T
Neuropharmacology; 2006 Sep; 51(4):914-22. PubMed ID: 16863654
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of nitric oxide on dopamine transporters: interneuronal communication without receptors.
Kiss JP; Zsilla G; Vizi ES
Neurochem Int; 2004 Sep; 45(4):485-9. PubMed ID: 15186914
[TBL] [Abstract][Full Text] [Related]
20. Effect of N omega-nitro-L-arginine methyl ester, a nitric oxide synthesis inhibitor, on stress- and morphine-induced prolactin release in male rats.
Matton A; Bollengier F; Finné E; Vanhaelst L
Br J Pharmacol; 1997 Jan; 120(2):268-72. PubMed ID: 9117119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
